Around two-thirds of women will develop at least one uterine fibroid in their lifetime, while one-third will be symptomatic. Black women are roughly two-to-three times more likely to develop UFs ...
The majority of women with uterine fibroids are asymptomatic, consequently get less clinical attention and fibroid tumors often remain undiagnosed. [23,24] Symptomatic women typically complain ...
Swiss biopharma company ObsEva has filed its oral GnRH antagonist linzagolix for the treatment of uterine fibroids in the US, hoping to expand the number of women eligible for this type of therapy.
This procedure is only appropriate for women who do not want to have more or any children. Fibroid-specific procedures—There are a number of procedures that can be used to remove or shrink the ...